Ex-Gilead GC Says He Didn't Calculate Teva's Gain In IP Deal
Gilead's ex-general counsel testified Tuesday in a "pay for delay" antitrust trial over its HIV drug patent deal with Teva, saying he never calculated a dollar value for the royalty-free license...To view the full article, register now.
Already a subscriber? Click here to view full article